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Abstract 
Hypromellose, HPMC, is frequently used to control drug release from matrix tablet 
formulations. Drug is released by a combination of diffusion through and erosion of, the 
matrix and is usually measured in vitro by separate dissolution and swelling/erosion 
studies. The present study was designed to measure matrix erosion, polymer dissolution 40 
and drug release kinetics and their inter-relationship in a single experiment using a phenol-
sulphuric acid assay to quantify dissolved HPMC alongside spectrophotometrical analysis 
of drug release. HPMC-based matrix tablets were manufactured containing two drugs at 
various drug:HPMC ratios. Drug release was determined and the degree of erosion was 
calculated by gravimetry. Results showed the matrix erosion rate and drug release were 45 
dependent on HPMC content and drug solubility, as expected. It was also apparent that the 
erosion rate was directly related to the drug release kinetics and comparative analysis of 
both matrix erosion techniques showed a high level of correlation. The findings show that 
a simple and inexpensive assay can be utilised not only to quantify HPMC but can also be 
used to calculate the degree of erosion of tablet matrices, negating the need for a separate 50 
study and providing a simplified practical approach that may be of use during product 
optimization.   
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 1- Introduction  60 
The use of hydrophilic matrices to develop extended release (ER) formulations has become 
progressively  widespread because of their potential to control the release of wide range of 
active pharmaceutical ingredients (APIs) and to produce robust tablet formulations 
(Alderman, 1984). Hydrophilic matrices containing hypromellose, HPMC (hydroxypropyl 
methylcellulose), as the polymeric carrier have been extensively used in oral dosage forms 65 
(Maderuelo et al., 2011). The popularity of HPMC can be attributed to its non-toxic nature, 
availability in different grades, good compression properties, ability to give pH independent 
drug release profiles, good regulatory acceptance and amenability to high levels of drug 
loading (Li et al., 2005). On incorporation of HPMC into the tablet formulation, the 
tortuosity and porosity of matrix tablets can be altered and are intuitively expected to 70 
influence the rate and mechanism of drug release from monolithic HPMC-based devices 
(Reza et al., 2003).  
Upon submersion in liquids, such as dissolution testing media or biological fluids, these 
hydrophilic matrices swell and polymer chains eventually disentangle which leads to the 
breakage of hydrogen bonds formed during tablet compaction. However, persistent liquid 75 
ingression and interaction between HPMC polymeric chains and the ingressing liquid can 
cause hydrogen bond formation accommodating water molecules (Gao et al., 1996).  This 
leads to the formation of gel layer across the matrix tablet as HPMC passes from an 
amorphous to rubbery state. (Colombo et al., 1999; Colombo et al., 2000; Jiasheng et al., 
2010). The polymeric chains present on the surface of matrix tablet hydrate quickly 80 
compared to those located inside the core and contact with liquid causes chain relaxation 
(swelling) which initiates erosion of the matrix. The relative rates of liquid uptake and 
erosion of a polymer matrix play a critical role in controlling the rate of drug release. The 
swelling, matrix erosion, drug release mechanism and rate are dependent on the 
concentration and viscosity of HPMC being used in the hydrophilic matrices (Mitchell et 85 
al., 1993; Wan et al., 1991). HPMC has the potential to hydrate quickly enough to form a 
gel layer before the drug entrapped in the tablet matrix can dissolve. Moreover, the higher 
the viscosity and density of the gel layer, the more resistant the gel is to dissolution and/or 
erosion as it can retain integrity, thus increasing drug diffusion path length (Khamanga and 
Walker, 2006).  Highly water soluble drugs diffuse through the gel layer before the matrix 90 
erodes but it is suggested that the presence of poorly soluble drugs can increase matrix 
erosion by imperilling the integrity of the gel layer (Bettini et al., 2001; Yang and Fassihi, 
1997). So, the solubility of entrapped drugs is another key factor in determining the drug 
release behaviour from hydrophilic matrices. Mechanistically both diffusion and erosion 
will be contributing factors in controlling drug release from a hydrophilic matrix tablet, 95 
however, in practical terms, one process will often play a dominant role over the other 
depending on the HPMC level and solubility of other matrix tablet contents (Sinha Roy and 
Rohera, 2002). 
Fundamentally during dissolution phenomena there are two processes involved by which 
polymer erosion from the hydrophilic matrices takes place. Firstly the disentanglement of 100 
individual polymeric chains at the surface of matrix tablets and secondly their subsequent 
transport to the surrounding bulk solution. The physical entanglement of the polymer chains 
precludes polymer dissolution but polymer present at the outermost surface is diluted by the 
bulk dissolution medium over time to a point when the polymeric network no longer has 
structural integrity. This eventually leads to polymer disentanglement and the matrix tablet 105 
starts to disappear (Colombo et al., 2000; Maderuelo et al., 2011; Miller-Chou and Koenig, 
2003; Siepmann and Peppas, 2001; Wen et al., 2010) .  
Various mathematical models have been reported including contributions from the role of 
water diffusion, polymer swelling, dissolution and degradation and drug diffusion (reviewed 
by Siepmann and Siepman, 2013). Similarly, there have been many techniques applied to 110 
determine the extent of water uptake and polymer erosion from hydrophilic matrices 
including photography, texture analysis, video recording and nuclear resonance (NMR) 
imaging  (Barba et al., 2009 a and b; Bettini et al., 2001; Cascone et al., 2014; Chirico et al., 
2007; Lamberti et al., 2013; Tajarobi et al., 2009) and gravimetric methods are the most 
commonly used technique to date (Chaibva et al., 2010; Dhopeshwarker and Zatz, 1993; 115 
Ebube et al., 1997; Franek et al., 2014; Ghimire et al., 2010; Khamanga and Walker, 2006; 
Ranga Rao et al., 1988; Sinha Roy and Rohera, 2002). Such measurements, however, can be 
relatively time consuming and laborious, requiring a significant amount of API and 
excipients. It has recently been shown that, for HPMC/lactose tablets, for example, that the 
choice of model for predicting drug release should be based on the desired accuracy and 120 
ease of application and often, simple equations may be adequate for the purpose (Siepmann 
et al., 2013). 
A number of analytical techniques can be used to measure carbohydrate concentration 
including size exclusion chromatography (Viridén et al., 2009), capillary electrophoresis 
(Cortacero-Ramírez et al., 2004), infrared (IR) spectroscopy (Cadet, 1999), nuclear 125 
magnetic resonance (NMR) micro-imaging (Tajarobi et al., 2009) and  light scattering 
detection (Zhang et al., 2008). Recently Viridén et al., (2009) successfully employed size 
exclusion chromatography to study HPMC tablet dissolution to determine the impact of 
HPMC heterogeneity on release. A phenol-sulphuric acid assay is commonly employed for 
analysing sugars in foods, including mono-, di- and polysaccharides and if successful would 130 
provide a simple method to study matrix erosion, negating requirements for separate 
analytical equipment and associated costs and time (Albalasmeh et al., 2013; Brummer and 
Cui, 2005; Masuko et al., 2005) .  
The aims of the present work were therefore multifold: firstly, to quantify HPMC in the 
dissolution medium by using novel application of a phenol-sulphuric acid alongside drug 135 
release studies. The Peppas and Korsmeyer model was applied to drug release profiles to 
attain mechanistic insight into the process (Korsmeyer et al., 1983). Secondly, the amount 
of dissolved HPMC and drug was used to calculate the degree and rate of erosion. 
Moreover, erosion was also determined using gravimetrical methods for comparative 
purposes; with an assumption that phenol-sulphuric acid assay will be an alternative option. 140 
Thirdly, the inter-relationship of HPMC erosion rate and drug release was studied. Fourthly, 
the impact of HPMC to drug ratio and the solubility of model drugs on matrix erosion, 
polymer dissolution and drug release kinetics were also studied, using theophylline 
(aqueous solubility, 7.3 g/L) and flurbiprofen (aqueous solubility, 8.0 mg/L) as model drugs 
(Yalkowsky et al., 2010).  145 
 2- Materials and methods  
 2.1- Materials 
 Flurbiprofen (FBP) and theophylline (THP) were purchased from Aesica Pharmaceutical 
Ltd, Cramlington, UK and Tokyo Chemical Industry Ltd, UK, respectively. Hydroxypropyl 
methyl cellulose, HPMC, (Methocel® K4M Premium) was a kind gift from Colorcon Ltd, 150 
Dartford, UK.  Sulphuric acid, hydrochloric acid and phenol were purchased from Sigma-
Aldrich, UK, and all were of analytical grade. Disodium hydrogen phosphate (Na2HPO4) 
and sodium dihydrogen phosphate (NaH2PO4) were purchased from Fisher Scientific, UK 
and used for the preparation of 0.2 M phosphate buffer (pH 7.2).  All the materials were 
used as received. 155 
2.2- Methods 
2.2.1- Preparation of matrix tablets  
 All the powder mixtures comprising different HPMC to drug ratios (flurbiprofen or   
theophylline, Table 1) were blended for 15 minutes (Turbula shaker-mixer). To evaluate the 
mixing efficiency, samples were removed from each powder mixture, theophylline and 160 
flurbiprofen content were determined by using the linear regression equation obtained from 
their respective UV standard calibration curves at 272 nm and 247 nm for theophylline and 
flurbiprofen, respectively. The final powder blends, having drug content between 95-105 %, 
were compacted using a manual hydraulic press equipped with 13.00 mm die set (Specac® 
Ltd, UK). The compact weight was maintained at 500 ± 2.5 mg each and was compressed at 165 
20 KN with a 20 second dwell time. At least 20 tablets for each batch of powder blend were 
made and assayed for theophylline and flurbiprofen using UV spectrophotometry as 
described above. Each determination was carried out in triplicate and mean results were 
reported. All the matrix tablets were stored in an air-tight container over silica gel for 24 
hours before further investigation.   170 
2.2.2- In vitro release studies  
2.2.2.1- Drug release studies 
In vitro drug release studies were performed on all the hydrophilic matrices, except those 
containing 100 % HPMC, using USP dissolution apparatus I, SR II 6-flask, basket 
apparatus, (Hanson Research, USA) at 100 rpm. pH 7.2 sodium phosphate buffer (900 ml) 175 
was used as the release medium and was maintained at 37.5 ± 0.5 °C. Aliquots of dissolution 
media (5 ml) were withdrawn manually after 30, 60, 120, 360, 740 and 1440 minutes and 
replaced with an equal amount of fresh dissolution medium. The dissolution samples were 
then analysed for drug content as before. 
 180 
2.2.2.2- HPMC dissolution studies 
HPMC dissolution was studied for all the hydrophilic matrix tablets. Dissolved HPMC was 
quantified using phenol-sulphuric acid assay alongside drug analysis on the removed 
samples described previously. Filtered samples (1 ml) were added to 1 ml of 5% phenol in 
0.1 M hydrochloric acid, followed by 5 ml of concentrated sulphuric acid. The resultant 185 
solution was mixed vigorously for 10 minutes and placed in a water bath at 25-30 °C for 20 
minutes. Absorbance was measured at maximum wavelength ( max) 490 nm and dissolved 
HPMC content was calculated from a standard calibration curve (Brummer and Cui, 2005; 
Dubois et al., 1956;).   
 190 
2.2.3- Erosion studies  
2.2.3.1- Gravimetrical method (GM) 
Erosion of matrix tablets was determined by a gravimetric technique (Chaibva et al., 2010; 
Dhopeshwarker and Zatz, 1993; Ebube et al., 1997; Ranga Rao et al., 1988; Sinha Roy and 
Rohera, 2002). The study was conducted using USP apparatus I, SR II 6-flask (Hanson 195 
Research, USA) at 100 rpm. The dry hydrophilic matrix tablets were accurately weighed 
and placed in baskets prior to immersion in dissolution media (pH 7.2 sodium phosphate 
buffer) which was maintained at 37 ± 0.5 °C. Tablets were removed at 30, 60, 120, 360, 720 
and 1440 minutes and lightly blotted dry with 125 mm filter paper (Whatman®) to remove 
excess water. They were subsequently dried in a convection oven at 50 °C. After 24 hours, 200 
the tablets were cooled to ambient temperature and then weighed until a constant weight 
had been achieved and this was termed the dried weight. All studies were conducted in 
triplicate. The degree of erosion (E) was calculated using equation 1.  
 
                               	
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Where, Wi is the initial weight of the matrix tablets and Wf is the weight of the dried 
matrices at specific sampling times. Water uptake can also be calculated using difference in 
weight between the tablet wet weight and the dried weight using this method. 
 210 
 
2.2.3.2- Combined dissolution method  
Matrix tablet erosion was also determined by using the collective amount of drug and 
polymer dissolved during dissolution and the percentage erosion was calculated at each 
sampling time using equation 2, and this method is subsequently termed sugar analysis 215 
technique (SA) in this paper. 
 
                          	
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× 100                            (2) 
 
where, Wd is amount of drug released (mg) and Wp is amount of HPMC dissolved (mg), 220 
determined using the phenol-sulphuric assay method in the dissolution medium at specific 
sampling times while Wi is the initial weight of matrix tablet.  Moreover, the HPMC degree 
of erosion (He) was also calculated by using the equation 3.   
 
                       	
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
× 100                              (3) 225 
 where, Wp is amount of dissolved HPMC (mg) and Wpi is the initial amount of HPMC in 
the matrix tablet.  
 
A graph was plotted between percentage matrix or HPMC erosion and time (up to 720 230 
minutes) for all the matrix tablets and simple linear regression was applied representing 
slope as an erosion rate (k, % min-1).  
2.2.4- Modelling of drug release profiles   
The mechanism and kinetics of drug release were deduced by fitting respective dissolution 
data to the Korsmeyer– Peppas model, equation 4 (Korsmeyer et al., 1983). The goodness 235 
of fit was established using the adjusted coefficient of determination where the closer the 
value is to 1, the better the data fit to the model. The value of diffusional exponent (n) is 
dependent on the mechanism of drug release and geometrical shape of the matrix that is 
being assessed and was further used to describe drug release patterns (Siepmann and 
Peppas, 2001). 240 
 
                                                     


=  !                                          (4) 
 
Where,  

  ,   is the fraction of drug released at time t while K is a drug release constant 
incorporating the geometrical characteristics of matrix tablet,  and n is diffusional exponent 245 
of drug release and used to elucidate the drug release mechanism. For cylindrical 
hydrophilic matrices, the n values of 0.45 are indicative drug release through Fickian 
diffusion and the values between 0.45 < n < 0.89 means drug is being released through 
anomalous transport.   
 250 
3- Results and discussion 
 3.1- Theophylline and flurbiprofen release studies 
HPMC present on the surface of matrix tablets initially hydrates during dissolution and 
forms an outer gel layer on matrix tablet surface. Progressive contact with the medium leads 
to subsequent bulk hydration of the matrix. Eventually, this leads to HPMC chain 255 
relaxation, followed by erosion of the matrix. The drug release rate and mechanism is 
controlled by the matrix swelling, diffusion of drug through the gel layer and/or matrix 
erosion.   
It was observed that the HPMC to drug ratio played an important role in regulating the 
release behaviour of theophylline and flurbiprofen from the hydrophilic matrix system.  260 
Theophylline and flurbiprofen release profiles are shown in Figure 1 (a and b), and for both 
drugs, HPMC ratio significantly affected the release rates, both decreasing with increasing 
HPMC content as polymer chain disentanglement slows  (Li et al., 2005; Maderuelo et al., 
2011). At higher levels of HPMC the increased concentration leads to chain entanglement 
which increases the tortuosity of matrix tablets (Chaibva et al., 2010; Mitchell et al., 1993) 265 
and can be considered a decisive feature impeding the diffusion of drug from the matrix gel 
layer during dissolution. An additional factor can be a lower porosity, as higher amount of 
HPMC corresponds to low matrix tablet porosity which exhibits low liquid movement 
across the surface of matrix tablet and leads to slower drug release rates (Reza et al., 2003). 
 A markedly faster drug release was determined for hydrophilic matrices containing 20% 270 
HPMC, and the release rates from matrices containing theophylline were faster than those 
with flurbiprofen.  The t60 and t120 of theophylline-containing matrices were higher than 
flurbiprofen matrices (Table 1). Rapid gel layer formation around the matrix tablet is an 
essential feature that can dictate drug release regardless of solubility of drug. Higher 
amounts of HPMC form a quicker but stronger gel layer which is more resistant to diffusion 275 
and/or erosion (Mitchell et al., 1993) .  
The mechanism by which drugs are released from hydrophilic systems can possibly be; (a) 
(diffusion- Fickian release), (b) non- Fickian or anomalous transport (c) zero-order release 
or case II mechanism.  Soluble drugs can act as pore formers in matrix tablets and have the 
capacity to form micro-cavities thus making the gel layer more porous increasing liberation 280 
into the bulk dissolution media through diffusion (Yang and Fassihi, 1997). Furthermore,  
poorly soluble drug (flurbiprofen) particles can be translocated through the gel layer with a 
spring-like action caused by transition of the  polymer chains from a glassy to a rubbery 
state, which disrupts the gel layer structure (Bettini et al., 2001) and can result in exposure 
of drug particles to water. To determine the mechanism of drug release, dissolution profiles 285 
were characterised using Korsmeyer-Peppas model (equation 4).  The diffusional exponent 
(n) of drug release is used to characterize the type of release mechanism during dissolution 
testing. The matrix tablets demonstrated a linear relationship with correlation coefficient 
within range 0.995 - 0.999 (Fig. 1 (a and b) and Table 1).  
Referring to the criteria of release kinetics from swellable cylindrical (Siepmann and 290 
Peppas, 2001) all tablet matrices, regardless of the drug, resulted in non-Fickian release 
(anomalous transport) mechanism (Table 1). The concentration of HPMC and drug in the 
matrices affect the diffusional exponent (n). With the gradual increase of HPMC, the n 
values decreased from 0.75 to 0.50 and 0.88 to 0.62, respectively for theophylline- and 
flurbiprofen-containing hydrophilic matrices. This indicates that the mechanism of release is 295 
a mixture of diffusion and erosion, however depending on the n values it can be predicted 
that the diffusion was the dominating mechanism for theophylline matrices whilst erosion 
dominated for flurbiprofen matrices.    
3.2- HPMC dissolution studies 
In this study, its release from matrix tablets containing varying concentrations of drug 300 
(theophylline or flurbiprofen), ranging from 0% to 80 % was quantified using the phenol-
sulphuric acid colorimetric assay. HPMC contains glucose monomers with different levels 
of methoxyl (%) and hydroxypropoxyl (%) substitution groups, so, it was expected that the 
phenol-sulphuric acid assay which is classically used to measure carbohydrate content in 
foods and beverages (Brummer and Cui, 2005) could be applied to quantify HPMC 305 
dissolution from tablets. UV-Vis spectrum scanning for both theophylline and flurbiprofen 
showed there was no interference with the assay at the wavelength of interest (max = 490 
nm).  
It can be seen in Figure 2 (a and b), that the rate and extent of HPMC dissolution fell with 
increasing HPMC content. This is attributed to a thicker, more durable gel layer on the 310 
matrix surface at higher concentrations. The release rates were concentration dependant and 
a similar trend was seen for both the formulations containing theophylline and flurbiprofen, 
i.e. 20 > 40 > 60 > 80 > 100%.  Despite HPMC being relatively soluble at pH 7.2, the 
mobility of the macromolecule is decreased with increasing HPMC levels. Methocel® K4M 
Premium, which is used in this study, has a high molecular weight and viscosity; therefore it 315 
is relatively resistant to polymer erosion compared to lower molecular weight and viscosity 
grades. The concentration of HPMC necessary to develop a rapid and strong gel layer 
around the matrix tablet is termed the critical concentration and indicates an ability to 
withstand the influence of different factors during dissolution or hydration. This is a 
desirable property of a polymer in controlled drug delivery system and the critical 320 
concentration is related to the thickness of the gel layer that forms and specific to each 
polymer (Maderuelo et al., 2011). It can be seen from Figure 2 (a and b) and Table 1 (t60 
and t120), that HPMC dissolution from flurbiprofen-containing matrices was higher than 
corresponding theophylline formulations because flurbiprofen is a poorly soluble drug and 
expected to jeopardise the integrity of gel layer, which can lead to faster HPMC dissolution. 325 
The presence of poorly soluble particles in the gel layer hinders the expansion of the 
polymer and decreases the resistance of the system to erosion, which increases the rate of 
release of the drug via erosion mechanisms (Table 1).  
 
3.3- Matrix tablets erosion studies 330 
In the hydrated gel layer on the matrix tablet surface, water exists in three distinct states;  
type I (freezable free or bulk water), type II (freezable bound water) and type III (bound 
water) (Asare-Addo et al., 2013a; Jhon and Andrade, 1973) and there is a moisture gradient 
which is present from the outer surface which is in contact with liquid to the inner dry 
polymeric matrix core (McCrystal et al., 1997). Once the polymer outer surface completely 335 
hydrates, the polymeric chains start to dissolve and this leads to matrix erosion. The erosion 
and drug dissolution rate are significantly influenced by the presence of drugs, viscosity, 
chemistry, ionic strength and particle size of drug and polymer (Asare-Addo et al., 2013a; 
Asare-Addo et al., 2013b; He et al., 2001; Li et al., 2005; Maderuelo et al., 2011).  
The degree of matrix erosion is shown in Figure 3 and 4, reported as % matrix erosion (E) 340 
and reflects the collective amount of polymer and drug dissolved. In the present study, the 
mass loss from the matrices increased gradually over time. The matrices prepared with 100 
% HPMC eroded slowly compared to those containing drugs (theophylline or flurbiprofen). 
Both methods for determining erosion, GM and SA, gave similar results, with the erosion 
rate of 100% HPMC matrices being 0.011 % min-1 (Table 2).  The matrices prepared with 345 
80:20, HPMC: THP have slowest erosion rate (GM = 0.033 and SA = 0.028 % min-1) and 
the rate tends to increase as HPMC content decreases. The erosion rate of matrices 
containing 20:80, HPMC: THP was 0.089 and 0.088 % min-1 respectively with SA and GM 
methods. Similarly the erosion rate of, 80:20, HPMC:FBP was lower (GM = 0.027 % min-1 
SA = 0.028 % min-1) increasing to 0.104 and 0.100 % min-1 respectively with both SA and 350 
GM methods as the HPMC levels declined in the  matrix tablets, suggesting that these 
matrices have reduced resistance to erosion. Moreover, it was obvious that erosion 
increased as the drugs were incorporated in the matrices (Table 2), with erosion rates being 
slower for the more water-soluble theophylline as described before.  
 355 
3.4- Quantitative relationship between GM and SA 
The validity of the phenol-sulphuric acid assay to study polymer dissolution and matrix 
erosion was determined by comparison with the more established gravimetric method. Mass 
balance was achieved in all cases and the matrix erosion rates and degree of matrix erosion 
(%) calculated using both techniques are reported in Table 2 and Figures 3 and 4, 360 
respectively. There was a high correlation between the results from both techniques (Figure 
5), with adjusted R2 of 0.998 and 0.988 for flurbiprofen and theophylline respectively 
(supplementary data).  Furthermore, matrix erosion (%) over time showed a higher degree 
of correlation when both methods were compared (Figure 6, a and b), with residual R2 
ranging between 0.986-0.998   and analysis of residuals showed random distribution about 365 
the horizontal axis (supplementary data).  The PSA assay can be used for determining 
neutral sugars in oligosaccharides, polysaccharides, proteoglycans, glycoproteins and 
protein lipds and can be scaled down to a microplate retaining sensitivity, with potential for 
high throughput screening, down to 1 nmol for some sugars (Masuko et al., 2005). This 
method determines the total sugars present as the sulfuric acid causes all non-reducing 370 
sugars to be converted to reducing sugars, so it is non-stoichemetric and therefore necessary 
to prepare a calibration curve using a series of standards of known carbohydrate 
concentration. The assay can provide a simple, cheap, robust and rapid analysis, and has 
been successfully applied in this study to determine dissolved HPMC and to characterise 
matrix erosion of hydrophilic matrices in in vitro dissolution studies.  375 
 
3.5- Inter-relationship between HPMC erosion and drug release kinetics  
It is apparent from results shown in Table 1 that as the HPMC to drug ratio in a matrix 
tablet varies, the drug release diffusional co-efficient (n) values change.  It can be predicted 
from the n values (Table 1) that both diffusion and erosion are involved during drug release.  380 
It has reported in previously that water soluble drugs were released dominantly by diffusion 
through the gelatinous layer and poorly soluble drugs by erosion of the matrix tablet  
(Bettini et al., 2001; Yang and Fassihi, 1997). This is corroborated in this study with erosion 
dominating when flurbiprofen was released and diffusion in the case of theophylline release.  
Figure 7 shows the relationship between the diffusional co-efficient (n) values of drugs and 385 
HPMC erosion rate (k), with a simple regression analysis applied to model the relationship.  
It is apparent that there is a linear relationship between the n values and HPMC erosion rate 
(k); the diffusional exponents are lower for the less water soluble drug, flurbiprofen, at all 
drug;polymer ratios, indicating that they are less dependent on diffusional drug release and 
thus a better correlation was apparent between n and polymer erosion rate. Poorly soluble 390 
drugs have the ability to disrupt the gel layer structure leading to higher degree of matrix 
erosion.   
Conclusion  
Although drug release from HPMC matrix devices is complex and multifaceted, this 
simplified practical approach can be used to assess the impact of formulation parameters on 395 
drug release during product development and optimisation. Hydrophilic matrices containing 
HPMC as the polymer and different drugs, theophylline and flurbiprofen, were evaluated 
for drug content, degree of matrix erosion, HPMC and drug release properties.  
A phenol-sulphuric acid assay was successfully adopted for the quantification of dissolved 
HPMC in the dissolution media. The HPMC dissolution rate increased as the level of 400 
HPMC decreased in the matrix tablets. Thus it leads to a conclusion that HPMC levels and 
solubility of drugs are important factors to consider during the designing of hydrophilic 
matrix tablet formulations.   
The release of FBP and THP was through an anomalous transport mechanism, however, 
Fickian diffusion and erosion dominated in THP and FBP matrices, respectively. The 405 
phenol-sulphuric acid assay also identified an inter-relationship between HPMC erosion 
rates (He) and Korsmeyer– Peppas parameter, n,  
The matrix erosion results obtained from newly adopted method, phenol-sulphuric acid 
assay confirm that the solubility of drug and levels of HPMC in a particular matrix tablet 
significantly affect the matrix erosion rate and results were similar to those determined 410 
using the much more labour-intensive gravimetric method. Moreover, the combination of 
conventional UV drug analysis technique and phenol-sulphuric acid assay can be used to 
simultaneously quantify the matrix erosion, polymer dissolution and drug release kinetics in 
a single set of experiments avoiding the need for separate studies.  
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Figure 5. Comparative analysis of erosion rates calculated from both techniques. 
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Figure 6. Comparative analysis of degree of erosion calculated using both techniques, 725 
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 Table 1, HPMC and drug release kinetics parameters of theophylline and flurbiprofen matrix tablets (standard deviation are in parenthesis) 750 
 
    
 
 
 755 
 
 
 
 
 760 
 t60 * = Percent drug/HPMC release at 60 minutes,  t120 ** = Percent drug/HPMC release at 120 minutes 
       
 
 
 765 
 
HPMC:Theophylline HPMC:Flurbiprofen 
Drug release kinetics 
parameters  t60 (%)* t120  (%)** 
n R2 Drug HPMC Drug HPMC 
100:0 100:0 - - - 1.05 - 1.56 
80:20 - 0.50 0.999 20.57 (1.02) 2.50 (0.12) 28.64 (1.43) 3.85 (0.19) 
60:40 - 0.61 0.990 25.38 (1.26) 3.58 (0.17) 38.31 (1.91) 5.50 (0.27) 
40:60 - 0.66 0.997 33.58 (2.43) 7.30 (0.36) 48.95 (2.44) 11.20 (0.56) 
20:80 - 0.75 0.999 48.69 (1.67) 17.67 (0.88) 80.32 (4.01) 28.52 (1.42) 
- 80:20 0.62 0.997 13.65 (0.68) 4.33 (0.21) 21.37 (1.06) 6.98 (0.34) 
- 60:40 0.64 0.994 20.64 (1.03) 9.65 (0.48) 32.68 (1.63) 17.32 (0.86) 
- 40:60 0.83 0.999 25.36 (1.26) 12.36 (0.61) 45.87 (2.29) 22.36 (1.11) 
- 20:80 0.88 0.995 40.31 (2.01) 21.98 (1.09) 68.96 (3.44) 34.89 (1.74) 
  
Table 2, Matrix erosion kinetics parameters of theophylline and flurbiprofen matrix tablets.   
 770 
 
 
 
 
 775 
 
 
 
 
                                             *SA = Sugar assay technique,  **GM = Gravimetrical method,  ***He  =  HPMC erosion rate 780 
 
 
 
HPMC:Theophylline HPMC:Flurbiprofen 
Erosion rates 
(k, %min-1) 
SA* R2 GM** R2 He*** R2 
100:0 100:0 0.011 0.918 0.011 0.915 0.011 0.918 
80:20 - 0.028 0.989 0.033 0.996 0.018 0.970 
60:40 - 0.052 0.946 0.049 0.937 0.027 0.997 
40:60 - 0.083 0.917 0.078 0.939 0.051 0.990 
20:80 - 0.089 0.716 0.088 0.716 0.099 0.903 
- 80:20 0.028 0.952 0.027 0.931 0.024 0.979 
- 60:40 0.050 0.874 0.047 0.874 0.047 0.899 
- 40:60 0.081 0.890 0.080 0.833 0.080 0.976 
- 20:80 0.104 0.734 0.100 0.710 0.112 0.853 
  
 
 
 
 
 
 
                                    
 
Figure 1, Residual plot of erosion rate, a comparison between GM and SA techniques. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2, Residual plot of comparative degree of erosion between GM and SA, 
theophylline matrices. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3, Residual plot of comparative degree of erosion between GM and SA, 
flurbiprofen matrices  
 
 
 
 
 
 
 
 
 
  
 
 
 
Table 1, Comparison of erosion rates of matrix tablets from gravimetrical and sugar 
assay from residual plots.  
 
 
 
Table 2, Comparison of degree of erosion (%) of matrix tablets from gravimetrical and 
sugar assay from residual plots (standard error is in parenthesis). 
 
 HPMC:Theophylline HPMC:Flurbiprofen Correlation co-efficient  
R2 
100:0 100:0 0.998 (0.18) 
80:20 - 0.986 (1.45) 
60:40 - 0.988 (1.99) 
40:60 - 0.991 (2.53) 
20:80 - 0.998 (1.17) 
- 80:20 0.994 (0.86) 
- 60:40 0.997 (0.87) 
- 40:60 0.986 (3.57) 
- 20:80 0.995 (2.68) 
Type of matrices Adjusted R2 Standard error 
Flurbiprofen matrices 0.998 0.0016 
Theophylline matrices 0.988 0.0034 
